Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

Little is known about the prognosis of patients with massive pulmonary embolism (PE) and its risk of recurrent venous thromboembolism (VTE) compared with non‐massive PE, which may inform clinical decisions. Our aim was to compare the risk of recurrent VTE, bleeding, and mortality after massive and non‐massive PE during anticoagulation and after its discontinuation.

[1]  M. Humbert,et al.  2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) , 2019, European Respiratory Journal.

[2]  M. Zuin,et al.  Thrombolysis in hemodynamically unstable patients: still underused: a review based on multicenter prospective registries on acute pulmonary embolism , 2019, Journal of Thrombosis and Thrombolysis.

[3]  M. Revel,et al.  [Recommendations for best practice in the management of venous thromboembolic disease in adults. Long version]. , 2019, Revue des maladies respiratoires.

[4]  R. Yusen,et al.  Meta-Analysis of Prevalence and Short-Term Prognosis of Hemodynamically Unstable Patients With Symptomatic Acute Pulmonary Embolism. , 2019, The American journal of cardiology.

[5]  R. Yusen,et al.  Epidemiology, patterns of care and mortality for patients with hemodynamically unstable acute symptomatic pulmonary embolism. , 2018, International journal of cardiology.

[6]  H. Krumholz,et al.  Rationale, Design and Methodology of the Computerized Registry of Patients with Venous Thromboembolism (RIETE) , 2018, Thrombosis and Haemostasis.

[7]  T. Baglin,et al.  Analysis of pulmonary embolus size at the time of recurrence compared with presentation: a single‐centre retrospective study , 2017, Journal of thrombosis and haemostasis : JTH.

[8]  D. Jiménez,et al.  Clinical Prognosis of Nonmassive Central and Noncentral Pulmonary Embolism: A Registry‐Based Cohort Study , 2017, Chest.

[9]  C. Coleman,et al.  Index clinical manifestation of venous thromboembolism predicts early recurrence type and frequency: a meta‐analysis of randomized controlled trials , 2015, Journal of thrombosis and haemostasis : JTH.

[10]  C. Combescure,et al.  Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis , 2014, European heart journal.

[11]  C. Cuccia,et al.  Clinical features and short term outcomes of patients with acute pulmonary embolism. The Italian Pulmonary Embolism Registry (IPER). , 2012, Thrombosis research.

[12]  J. Kline,et al.  Therapy and outcomes in massive pulmonary embolism from the Emergency Medicine Pulmonary Embolism in the Real World Registry. , 2012, The American journal of emergency medicine.

[13]  L. Trinquart,et al.  Perfusion defects after pulmonary embolism: risk factors and clinical significance , 2010, Journal of thrombosis and haemostasis : JTH.

[14]  S. Laporte,et al.  Thromboembolism : Findings From the Registro Informatizado de la Enfermedad Clinical Predictors for Fatal Pulmonary Embolism in 15 520 Patients With Venous , 2008 .

[15]  F. Schiele,et al.  In-hospital and long-term outcome after sub-massive and massive pulmonary embolism submitted to thrombolytic therapy. , 2003, European heart journal.

[16]  Samuel Z Goldhaber,et al.  Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) , 1999, The Lancet.

[17]  E. Klofas.  Massive pulmonary embolism. , 1989, The American journal of emergency medicine.